CurrentCardio
Get Weekly

Topic · page 16 of 21

Prevention & lipids

Lipids, Lp(a), lifestyle (activity, diet, alcohol, smoking), risk scores, primary prevention in general or older populations, frailty and CV risk

Briefs 601–640 of 838 placed here, newest publication first

Briefs in Prevention & lipids

Newest publication first

  1. J Am Coll Cardiol

    The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering: OCEAN(a)-DOSE Extension Period Results

    Secondary analysis

  2. Eur J Prev Cardiol

    Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol

    Cross-sectional study

  3. Eur J Prev Cardiol

    The relationship of cardiorespiratory fitness, physical activity, and coronary artery calcification to cardiovascular disease events in CARDIA participants

    Cohort study

  4. Eur Heart J

    Device-measured physical activity and cardiac structure by magnetic resonance

    Cross-sectional study

  5. Eur J Prev Cardiol

    Hypnotic use and the risk of cardiovascular diseases in insomnia patients

    Cohort study

  6. J Am Coll Cardiol

    Effect of Time-Varying Exposure to School-Based Health Promotion on Adiposity in Childhood

    Randomised controlled trial

  7. Eur J Prev Cardiol

    The future of education in Preventive Cardiology: a statement of the European Association of Preventive Cardiology of the European Society of Cardiology

    Guideline or statement

  8. Eur J Prev Cardiol

    Association of accelerometer-derived physical activity with all-cause and cause-specific mortality among individuals with cardiovascular diseases: a prospective cohort study

    Cohort study

  9. Circulation

    Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA)

    Cohort study

  10. Circulation

    Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)

    Cohort study

  11. JAMA Cardiol

    Climate Change and Cardiovascular Health: A Systematic Review

    Meta-analysis

  12. JAMA Cardiol

    Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non–HDL-C Levels

    Cross-sectional study

  13. J Am Coll Cardiol

    Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary Prevention

    Diagnostic or prognostic study

  14. Eur J Prev Cardiol

    Trends in atherosclerotic cardiovascular disease and lipid management: a population-level observational cohort study in Wales

    Cohort study

  15. Eur J Prev Cardiol

    Cardiac rehabilitation and frailty: a systematic review and meta-analysis

    Meta-analysis

  16. Eur Heart J

    Randomized 20-year infancy-onset dietary intervention, life-long cardiovascular risk factors and retinal microvasculature

    Secondary analysis

  17. J Am Coll Cardiol

    Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs

    Secondary analysis

  18. J Am Coll Cardiol

    Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol– or Apolipoprotein B–Related Risk of Coronary Heart Disease

    Cohort study

  19. Eur Heart J

    Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis

    Meta-analysis

  20. JAMA Cardiol

    Physical Activity and Progression of Coronary Artery Calcification in Men and Women

    Cohort study

  21. JAMA Cardiol

    Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial

    Randomised controlled trial

  22. Circulation

    Associations of Urban Blue and Green Spaces With Coronary Artery Calcification in Black Individuals and Disadvantaged Neighborhoods

    Secondary analysis

  23. Eur J Prev Cardiol

    Trends in population attributable fraction of modifiable risk factors for cardiovascular diseases across three decades

    Cohort study

  24. Circulation

    Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL

    Cohort study

  25. Circulation

    Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid (RESPECT-EPA)

    Randomised controlled trial

  26. Eur J Prev Cardiol

    Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis

    Meta-analysis

  27. Eur J Prev Cardiol

    Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study

    Cohort study

  28. J Am Coll Cardiol

    Excess Apolipoprotein B and Cardiovascular Risk in Women and Men

    Cohort study

  29. Eur Heart J

    Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy

    Research article

  30. Eur J Prev Cardiol

    Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals

    Cross-sectional study

  31. Eur Heart J

    Xylitol is prothrombotic and associated with cardiovascular risk

    Cohort study

  32. Eur J Prev Cardiol

    Health-related quality of life in elderly cardiac patients undergoing cardiac rehabilitation and the association with exercise capacity: the EU-CaRE study

    Cohort study

  33. Circulation

    Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association

    Research article

  34. Circulation

    Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association

    Research article

  35. JAMA

    Non–High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events

    Meta-analysis

  36. Eur J Prev Cardiol

    The relationship between low levels of albuminuria and mortality among adults without major cardiovascular risk factors

    Cohort study

  37. N Engl J Med

    Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia

    Randomised controlled trial

  38. N Engl J Med

    Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia

    Randomised controlled trial

  39. Eur J Prev Cardiol

    Strike early–strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry

    Cohort study

  40. Eur J Prev Cardiol

    Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions

    Diagnostic or prognostic study

All 838 Briefs in ExploreShowing Briefs 601–640 of 838, newest first